- Direction
- Unknown
- Own history
- —
- Peers
- 54th
- Persistence
- TRANSIENT
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTImmunocore Holdings plc's latest supported as-filed period reports revenue of $115.9M, 18.3% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.68% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 13.74% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 18.34% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 6.72% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 99.06% · CORE
Level · gp.fundamentals.operating_margin
Raw value -2.58% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 42.8%; Inventory / revenue moved 115 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 18.3%; Operating margin moved 1260 bp higher; Operating income increased 79.9%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 0.6%; Operating cash flow decreased 38.7%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 89.9%; Capex / revenue moved 26 bp higher.
2 evidence-backed componentsInventory changed +42.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
IMCR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001671927-26-000026SEC ↗10-QAug 6, 2026Period Jun 30, 20260001671927-26-000022SEC ↗8-KAug 6, 2026Period Aug 6, 20260001671927-26-000020SEC ↗4May 28, 2026Period May 27, 20260001969518-26-000002SEC ↗4May 28, 2026Period May 27, 20260001508596-26-000002SEC ↗4May 28, 2026Period May 27, 20260001919343-26-000002SEC ↗4May 28, 2026Period May 27, 20260001969522-26-000002SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| May 27, 2026Filed May 28, 2026 | Ratcliffe Peter JohnDirector | Grant Or AwardDirect | 27,492 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 63.79% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 8.11% · OPTIONAL
Free-cash-flow proxy changed -40.7% from the comparable as-filed period.
Operating income changed +79.9% from the comparable as-filed period.
Operating cash flow changed -38.7% from the comparable as-filed period.
Operating margin changed +1260 basis points from the comparable as-filed period.
Current liabilities changed +38.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +18.3% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001969520-26-000002